Early detection can mean the difference between life and death.
Maori people constitute 14.5% of New Zealand's 4.3 million population, and Pacific people make up 6.9% of the population. 1
And accounts for 30% of deaths annually.
Our Clinical Research Group has developed a new early detection method for pulmonary vascular disease – or high blood pressure in the lungs – a severe condition affecting young adults.
Heart failure is generally only clinically apparent once the disease process is advanced, leaving the clinician with limited treatment options. The Cardiac Imaging Group is developing 4-dimensional flow magnetic resonance imaging (4D-flow MRI), technology that is set to revolutionise not just cardiac imaging, but the daily practice of cardiology.